Related Experiment Video
Updated: Jun 3, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
[Nonalcoholic steatohepatitis. Predictor and consequence of diabetes]
1Abteilung für Endokrinologie, Diabetologie, Vaskuläre Medizin, Nephrologie und Klinische Chemie, Innere Medizin, Universitätsklinik Tübingen, Mitglied des Deutschen Zentrums für Diabetesforschung (DZD) e.V., Tübingen. norbert.stefan@med.uni-tuebingen.de
Abstract:
Nonalcoholic fatty liver (NAFL) and particularly nonalcoholic steatohepatitis (NASH) are not only risk factors for liver fibrosis, liver cirrhosis and hepatocellular carcinoma, but are also strongly associated with insulin resistance and type 2 diabetes. This is probably due to the fact that the same mechanisms are operative in the pathogenesis of these diseases. In addition fatty liver predicts incident type 2 diabetes, but also atherosclerosis, indicating a causal role of fatty liver in the pathogenesis of these diseases. This hypothesis is supported by novel findings deriving from translational research involving precise genotyping and phenotyping strategies in humans. The precise investigation of mechanisms involved will deliver new knowledge which may be important for the prevention and therapy of these diseases.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology
Type II Diabetes I: Introduction
Diabetic Nephropathy
Type I Diabetes II: Pathophysiology
Chronic Pancreatitis I: Introduction

